Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort.
Bajaj JS, Idilman R, Mabudian L, Hood M, Fagan A, Turan D, White MB, Karakaya F, Wang J, Atalay R, Hylemon PB, Gavis EA, Brown R, Thacker LR, Acharya C, Heuman DM, Sikaroodi M, Gillevet PM. Bajaj JS, et al. Among authors: karakaya f. Hepatology. 2018 Jul;68(1):234-247. doi: 10.1002/hep.29791. Epub 2018 May 10. Hepatology. 2018. PMID: 29350768
Impact of Periampullary Diverticula on Bile Duct Stones and Ampullary Carcinoma.
Örmeci N, Deda X, Kalkan Ç, Tüzün AE, Karakaya F, Dökmeci A, Bahar DK, Özkan H, İdilman R, Çınar K. Örmeci N, et al. Among authors: karakaya f. Euroasian J Hepatogastroenterol. 2016 Jan-Jun;6(1):31-34. doi: 10.5005/jp-journals-10018-1162. Epub 2016 Jul 9. Euroasian J Hepatogastroenterol. 2016. PMID: 29201721 Free PMC article.
HOW TO CITE THIS ARTICLE: Ormeci N, Deda X, Kalkan C, Tuzun AE, Karakaya F, Dokmeci A, Bahar DK, Ozkan H, Idilman R, Cinar K. Impact of Periampullary Diverticula on Bile Duct Stones and Ampullary Carcinoma. ...
HOW TO CITE THIS ARTICLE: Ormeci N, Deda X, Kalkan C, Tuzun AE, Karakaya F, Dokmeci A, Bahar DK, Ozkan H, Idilman R, Cinar K. …
Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences.
Örmeci N, Sezgin O, Karaali R, Aygen B, Turan D, Yaras S, Erdem İ, Yildiz O, Karakaya F, Ateş K, Asiller ÖÖ. Örmeci N, et al. Among authors: karakaya f. Eur J Gastroenterol Hepatol. 2019 Apr;31(4):534-539. doi: 10.1097/MEG.0000000000001334. Eur J Gastroenterol Hepatol. 2019. PMID: 30672829
A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis.
Yurdaydin C, Keskin O, Yurdcu E, Çalişkan A, Önem S, Karakaya F, Kalkan Ç, Karatayli E, Karatayli S, Choong I, Apelian D, Koh C, Heller T, Idilman R, Bozdayi AM, Glenn JS. Yurdaydin C, et al. Among authors: karakaya f. Hepatology. 2022 Jun;75(6):1551-1565. doi: 10.1002/hep.32259. Epub 2021 Dec 23. Hepatology. 2022. PMID: 34860418 Clinical Trial.
36 results